ArticleAmerican journal of cancer research2026
UBE2J2-mediated ubiquitination modification of MCM6 regulates proliferation and migration of cervical cancer cells.
Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microchromosome maintenance protein 6 (MCM6), a member of the MCM family, is involved in the regulation of various cancer progression. However, the role and related regulatory mechanisms in cervical cancer are unclear. The aim of this study was to investigate the role of MCM6 in cervical cancer and the regulation of MCM6 protein homeostasis by the ubiquitin-conjugating enzyme E2J2 (UBE2J2). To investigate the expression and function of MCM6 in cervical cancer, we used RT-qPCR and Western blot and found that MCM6 was upregulated. Cell function experiments indicate that MCM6 promotes the proliferation and migration of cervical cancer cells. The GEPIA database identified co-expressed genes with MCM6, and KEGG enrichment analysis showed that MCM6 was significantly associated with UBE2J2. We performed molecular docking of proteins and identified amino acid residues involved in the MCM6-UBE2J2 interaction. Using co-immunoprecipitation and Immunofluorescence experiments, we found that MCM6 binds to UBE2J2 and localizes to the nucleus. Ubiquitination experiments demonstrated that UBE2J2 mediates MCM6 ubiquitination. Response experiments showing that UBE2J2-mediated MCM6 ubiquitination modification regulates the proliferation and migration of cervical cancer cells. Our results suggest that the UBE2J2-MCM6 axis plays an important role in regulating cervical cancer proliferation and migration and is a promising therapeutic target for its treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.